Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00127465
Other study ID # ESRC-L328253025
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received August 4, 2005
Last updated December 10, 2008
Start date November 2001
Est. completion date July 2003

Study information

Verified date August 2005
Source University of Plymouth
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Interventional

Clinical Trial Summary

Objective: To explore the hypothesis that different methods of selecting and printing information for cancer patients could improve emotional support by affecting interaction with others, and so lead to improved psychological wellbeing.

Design: Randomised trial with 8 groups (three factors, 2X2X2). Data collected at recruitment and three month follow-up.

Participants: 400 patients starting radiotherapy and their 'confidant' (the person in who they confide).

Interventions: Printed booklets.

1. Half had 'general' CancerBACUP information for that cancer; half had 'personal' information from the medical record plus selected general information;

2. Half chose information by 'interacting' with the computer; half had a larger volume of material in booklets that were produced 'automatically'.

3. Half had additional 'anxiety management advice'.

Outcomes: Patients' views; use of booklet with others; change in reported social support; change in anxiety and depression.


Description:

Aim:

- Based on a randomised trial the researchers aimed to model use of leaflets in the home as a function of three factors:

1. whether patients chose the information themselves or if it was chosen for them;

2. whether it included personal information from their own medical record or not;

3. whether it included anxiety management advice or not.

- The researchers aimed to model patient and confidant's anxiety at three months as a function of these three factors and patients' use of leaflets in the home.

Patient Population: Beatson Oncology Centre (BOC). Patients thought to be eligible were to be identified from outpatient appointment diaries over fifteen months. Medical records were to be checked for all those initially identified to ensure that patients have breast, gynaecological, prostate or bladder or testicular, or selected cancers of the head or neck. Patients excluded were to be those:

- receiving palliative treatment,

- with no knowledge or understanding of their diagnosis (very few),

- with visual or mental handicap,

- with severe pain or symptoms causing distress,

- medical or nursing students,

- taking part in other trials with possibly confounding interventions, and

- those not giving informed consent.

Sample size: The researchers aimed to recruit 400 patients. This was to give 80% power to find a difference between 40% and 27% who have improved anxiety between (eg) 200 in personalised group and 200 in general group.

Recruitment: Eligible patients were to be sent a letter explaining the study and advising them that a researcher will approach them in a visit to the BOC soon after, to seek participation in the study. Patients were not to be recruited at their bad news consultation but as soon as possible thereafter and at any point in their course of contact and treatment at the Beatson. At recruitment the researcher was to further explain the study and seek written consent. If the patient consented the researcher was to arrange a time for the intervention and give the patient a questionnaire to take home to complete themselves and a questionnaire for their 'confidant'.

Baseline data: Patients were to be asked to bring the completed questionnaire with them to the intervention consultation about one week later. The questionnaire included the following sections:

1. previous computer and information use, perceived knowledge, significant others in providing emotional support, family and living arrangements,

2. a Hospital Anxiety and Depression Scale (HADS),

3. a Miller Coping Style questionnaire,

4. Helgeson's measures of social support and negative interactions.

Completion of this questionnaire should have taken about half an hour at home.

Confidants: The researchers aimed to recruit 400 'confidants', one for each patient (but estimated that it were more likely to recruit (say) 60% of 400. Patients were to be asked if they were prepared to pass on the baseline questionnaire to a person selected by them as the person they are most likely to use to seek emotional support. This may be a husband, wife, partner, but may also be a daughter, son, or friend. The confidant questionnaire has sections:

1. demographics and relationship to patient, newspaper read, frequency of discussion with patient, perceived knowledge

2. HADS,

3. Miller coping style.

The researchers did not know what proportion of patients would be prepared to pass on the questionnaire or what response rate would be received from confidants. Rees in her work with daughters of women with breast cancer found that 93% of patients passed the questionnaires on and 77% of daughters responded. If we got an overall 60% response (ie 240 before and after questionnaires) this would give us 80% power to find a difference between 40% and 23% who had improved anxiety between (eg) 120 in personalised group vs 120 in general group. The confidant population would be less than the patient population. Patients will not be excluded if there is no corresponding 'confidant'.

Randomisation for the three factors: After recruitment the RA was to randomise for each of the three binary factors (2X2X2 factorial design):

A. Interactive v Automatic;

B. Medical Record v General;

C. Anxiety reducing advice v no advice.

Patients were to randomised to the eight sub-groups in blocks of 32 and separately by breast vs rest. The eight (2X2X2) subgroups, each receive different styles of leaflet. These are detailed further below.

Baseline Data: Collected from case notes was to be severity, length of onset of cancer, treatments so far (surgery, radiotherapy, chemotherapy), date of birth, gender, address, deprivation category from postcode for all patients, and a problem and treatment list for patients in the 'medical record' groups.

Intervention: The delay between recruitment and intervention was to allow patients time to think about their participation and withdraw if desired. At the intervention, patients were to produce a report about their cancer. Patients in the 'automatic group' would not need to use the computer.

- Interactive vs automatic. Those in the 'interactive' groups were to choose from menus, see information on the screen, and press an 'add to report' button on information screens for that information which they want to include in their report. Patients' choices were to be recorded by the computer.

- Those in the medical records group were to have personal information included based on their medical record. They were to either have information automatically selected and formatted by the computer, or to see it on screen and choose what they want to include.

- Lastly, half the patients were to have an additional section offering advice for the reduction of anxiety. This section was written based on previous work in cognitive behavioural therapy for anxiety.

All reports were to include colour photos (for example of treatment rooms, staff), and diagrams (for example, anatomical) of good quality printing etc. The patient were to be given the report to take away.

Three month follow-up: At three months patients were to be sent a follow-up questionnaire with the following sections:

1. questions about their satisfaction with the information received, their use of their reports, their interactions with their family and friends, and the influence of the reports on these interactions, their perceived knowledge.

2. HADS,

3. Helgeson's social support questionnaires.

Significant others will be sent a questionnaire which has sections on:

1. questions about their satisfaction with the information they have received,

2. HADS

Measures of Outcome:

- Change in anxiety (for patient or confidant) between intervention and 3 month follow-up (HADS)

- Change in social support (for patient) between intervention and 3 months (Helgeson)

- Patient satisfaction with information score at 3 month follow-up

- Confidant satisfaction with information score at 3 month follow-up

- Whether patient had read report, shown it or discussed it with the named confidant, other family members or friends and whether the discussion was aided by use of the report.

- What patients liked and disliked about the reports.

- Amongst the interactive group, choices made between presentation styles and how well these would correspond to automatic computer choices.

- Patient and staff time, and hence costs, needed for routine delivery of each intervention will be modelled on a variety of assumptions.

Analysis: The researchers were to produce a CONSORT patient flow diagram and compare losses to follow-up by the three interventions (A,B,C). Analysis of outcomes was to be for those patients completing both intervention and follow-up. The researchers will focus on the following:

- Comparison of outcomes 1-4 by interventions A, B, and C while controlling for age, gender, cancer site, time since diagnosis, severity, coping style, using analysis of variance (factorial design) and multiple logistic regression.

- Comparison of outcomes 5 and 6 by interventions A,B, and C (qualitative).

- Modelling of anxiety (outcomes 1-2) on use of report at home (outcome 4), perceived social support, and interventions A,B,C.

- Frequencies of choices (outcome 7) and comparison with automatic selection, both statistically and through qualitative description of the differences.

- Comparison of patient and NHS costs (outcome 8) will be made between the methods used in this trial and other methods of providing information.

- Comparison of anxiety change in patient and significant other.

- Analyses will be on those completing follow-up. No substitution of data will be carried out for those randomised but not completing follow-up. The researchers will thus be able to make provisional conclusions on how the different types of information provision influence interaction, anxiety and patient satisfaction, and on the correlation between the use of information with family, and anxiety; The researchers will have information on patient selection to inform the better development of automatic systems, and costs to inform practical deployment.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date July 2003
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients starting outpatient radiotherapy treatment with breast, prostate, cervical or laryngeal cancer

Exclusion Criteria:

- Receiving palliative care

- Severe pain or symptoms causing distress

- Having cancer at other sites

- Having no spoken English

- Receiving treatment for psychological or psychiatric problems

- Visual or mental handicap

- Having case notes not available or ambiguous or illegible.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label


Intervention

Procedure:
Issue of information booklet


Locations

Country Name City State
United Kingdom Beatson Oncology Centre Glasgow

Sponsors (1)

Lead Sponsor Collaborator
University of Plymouth

Country where clinical trial is conducted

United Kingdom, 

References & Publications (2)

Jones RB, Pearson J, Bental D, Cawsey A, Gilmour WH, Barrett A et al. The effect of tailored reports on the anxiety of cancer patients. Final Report to ESRC on grant number L328253024, February 2004. (Details available on the Economic and Social Research

Jones RB, Pearson J, Cawsey AJ, Bental D, Barrett A, White J, White CA, Gilmour WH. Effect of different forms of information produced for cancer patients on their use of the information, social support, and anxiety: randomised trial. BMJ. 2006 Apr 22;332( — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary patients' views three months after intervention
Primary use of booklet with others between intervention and three month follow up
Primary change in reported social support between recruitment and three month follow up
Primary change in anxiety and depression between recruitment and three month follow up
Secondary confidants' views three months after intervention
Secondary change in confidants' anxiety and depression between recruitment and three month follow up
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05558917 - Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery N/A
Active, not recruiting NCT03664778 - Abbreviated Breast MRI After Cancer Treatment
Recruiting NCT03144622 - 18F-FSPG PET/CT Imaging in Patients With Cancers
Completed NCT05452499 - Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae N/A
Active, not recruiting NCT04568902 - Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer Phase 1
Completed NCT02860585 - Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation N/A
Completed NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis Phase 2/Phase 3
Recruiting NCT04557449 - Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors Phase 1/Phase 2
Completed NCT03698942 - Delphinus SoftVueâ„¢ ROC Reader Study
Completed NCT00092950 - Exercise in Women at Risk for Breast Cancer Phase 2
Terminated NCT04123704 - Sitravatinib in Metastatic Breast Cancer Phase 2
Not yet recruiting NCT02151071 - The Breast Surgery EnLight and LightPath Imaging System Study Phase 1/Phase 2
Recruiting NCT02934360 - TR(ACE) Assay Clinical Specimen Study N/A
Active, not recruiting NCT02950064 - A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations Phase 1
Completed NCT02931552 - Nuevo Amanecer II: Translating a Stress Management Program for Latinas N/A
Not yet recruiting NCT02876848 - A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study) N/A
Recruiting NCT02547545 - Breast Cancer Chemotherapy Risk Prediction Mathematical Model N/A
Completed NCT02303366 - Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475 Phase 1
Completed NCT02518477 - Preventive Intervention Against Lymphedema After Breast Cancer Surgery N/A
Completed NCT02652975 - Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium N/A